Navigation Links
Marrone Bio Innovations Announces Two New Executive Appointments

DAVIS, Calif., Dec. 11 /PRNewswire/ -- Marrone Bio Innovations (MBI) today announces 2 new additions to its executive management team. Mr. Chris Hildreth joined MBI as Senior Vice President of Commercial Operations, and is responsible for expanding all commercial aspects of the company, including sales, marketing, and business development functions. Dr. Kin Sing (Ray) Lam joined MBI as Vice President of Process Development, and leads the company's development efforts in scaling its broad pipeline of products to commercial manufacturing scale.

Chris Hildreth has extensive experience in the agricultural chemical industry, providing successful general management of sales organizations driven by profitable growth. Prior to arriving at MBI, he was Sr. Vice President and Director of Sales at AMVAC Corporation from 2003 to mid-2009. Before that, Hildreth held various sales and general management positions with United Agri Products, Inc., including Executive Vice President International, President and General Manager Distribution, President Products Company, United Agri Products Inc. and General Manager, UAP Canada.

"Chris is a highly accomplished and well-respected business manager and his extensive industry sales experience and complementary management style will be invaluable as he drives commercial growth at MBI," said Pam Marrone, Founder and CEO of Marrone Bio Innovations.

"I am very happy to be a part of the Marrone team," said Chris Hildreth. "Marrone Bio Innovations already has two efficacious products being sold commercially and an incredibly exciting pipeline. Natural products usage is increasing rapidly in both organic and standard crop production, as the efficacy of new products equals that of chemical products. The growth of natural product usage and Marrone Bio Innovations will be exceptional."

Dr. Ray Lam comes to MBI as an experienced and successful leader of multi-disciplinary teams of scientists in natural product discovery and development. He has a proven track record of advancing projects through developmental stages to industrial production. Prior to joining MBI, Ray was Vice President, Microbiology and Industrial Fermentation at Nereus Pharmaceuticals in San Diego, CA where he designed and developed the Marine Microbial Drug Discovery program. Before that, he was a Senior Principal Scientist in the Natural Products Department at Bristol-Myers Squibb Company in Connecticut.

"We are pleased to attract such a distinguished scientist and leader as Ray to lead our process development efforts," states Marrone. "With his extensive natural products experience, he will contribute scientifically to all of the company's R&D efforts from discovery through to commercial scale up."

Dr. Lam received his Ph.D. in Biochemistry from the University of Calgary, Calgary, Alberta, Canada and his M.A. and B.A. in Chemistry from the State University College of New York, Plattsburgh, New York. He is a long-standing member of several professional associations including the American Chemical Society, the American Society for Microbiology and the Society for Industrial Microbiology.

Marrone Bio Innovations (MBI) discovers, develops and markets effective and environmentally responsible products that fill unmet needs for weed, disease and pest management. MBI's effective and safe products come from a combination of in-licensed technology and its own discovery. The company's own R&D finds naturally occurring microorganisms from unique habitats and develops them into pest management products. MBI has an impressive pipeline of new products, including two insecticides, two herbicides and Zequanox(TM), a product for controlling invasive zebra and quagga mussels in fresh waterways. MBI currently markets Regalia® for control of fungal and bacterial diseases of both food and ornamental crops, and GreenMatch® Burndown Herbicide for weed control in organic crop production.

SOURCE Marrone Bio Innovations

SOURCE Marrone Bio Innovations
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Marrone Bio Innovations Named an IC20 Company
2. Elekta To Showcase Innovations in Radiotherapy and Unveil New Product That Expands Cancer Treatment Availability
3. Atrium Innovations Announces Management Changes
4. Small Bone Innovations Introduces the Artelon(R) STT Spacer to Increase Treatment Options for Thumb Arthritis
5. Small Bone Innovations Introduces New Distal Radius Plating System to Repair Complex Fractures
6. Inverness Medical Innovations Agrees to Acquire Panbio Ltd.
7. Atrium Innovations to Hold 2007 Third Quarter Financial Results Conference Call and Webcast on November 8
8. Inverness Medical Innovations Announces Proposed Public Offering of Common Stock
9. Inverness Medical Innovations Agrees to Acquire ParadigmHealth
10. Inverness Medical Innovations Acquires ParadigmHealth
11. Inverness Medical Innovations to Participate at JP Morgan Healthcare Conference on January 8, 2008
Post Your Comments:
(Date:6/27/2016)... 27, 2016  Global demand for enzymes is ... 2020 to $7.2 billion.  This market includes enzymes ... products, biofuel production, animal feed, and other markets) ... biocatalysts). Food and beverages will remain the largest ... consumption of products containing enzymes in developing regions.  ...
(Date:6/27/2016)... ... June 27, 2016 , ... Cancer ... what they believe could be a new and helpful biomarker for malignant pleural ... Click here to read it now. , Biomarkers are components in the ...
(Date:6/27/2016)... , ... June 27, 2016 , ... ... for Amgen, will join the faculty of the University of North Carolina ... professor of strategy and entrepreneurship at UNC Kenan-Flagler, with a focus on the ...
(Date:6/24/2016)... on a range of subjects including policies, debt and investment ... Speaking at a lecture to the Canadian Economics ... the country,s inflation target, which is set by both the ... "In certain areas there needs to be frequent ... not sit down and address strategy together?" He ...
Breaking Biology Technology:
(Date:5/16/2016)... 16, 2016   EyeLock LLC , a market ... opening of an IoT Center of Excellence in ... the development of embedded iris biometric applications. ... convenience and security with unmatched biometric accuracy, making it ... from DNA. EyeLock,s platform uses video technology to deliver ...
(Date:5/3/2016)... , May 3, 2016  Neurotechnology, a ... the MegaMatcher Automated Biometric Identification System (ABIS) ... large-scale multi-biometric projects. MegaMatcher ABIS can process multiple ... using any combination of fingerprint, face or iris ... MegaMatcher SDK and MegaMatcher Accelerator , ...
(Date:4/26/2016)... India and LONDON ... Infosys Finacle, part of EdgeVerve Systems, a product ... and Onegini today announced a partnership to integrate ... solutions.      (Logo: ... to provide their customers enhanced security to access ...
Breaking Biology News(10 mins):